Marrone Bio Innovations, Inc.
MBII
MBII was delisted on the 12th of July, 2022.
23 hedge funds and large institutions have $19.5M invested in Marrone Bio Innovations, Inc. in 2016 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 5 closing their positions.
22% more capital invested
Capital invested by funds: $16.1M → $19.5M (+$3.47M)
0% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 3
8% less funds holding
Funds holding: 25 → 23 (-2)
40% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SIM
Spark Investment Management
New York
|
+$122K |
| 2 |
RJFSA
Raymond James Financial Services Advisors
St. Petersburg,
Florida
|
+$50.1K |
| 3 |
SC
Savant Capital
Rockford,
Illinois
|
+$23.1K |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$2.25K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$957 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Senvest Management
New York
|
-$210K |
| 2 |
Primecap Management
Pasadena,
California
|
-$162K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$88.9K |
| 4 |
WRF
Waddell & Reed Financial
Overland Park,
Kansas
|
-$87.4K |
| 5 |
EAM
Evanson Asset Management
Carmel,
California
|
-$38K |
MBII Hedge Fund Activity: Q4 2016 in Review
23 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Marrone Bio Innovations, Inc. (MBII) for Q4 2016, worth a combined $19.5M — up 22% from $16.1M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of MBII and 3 opened new positions — a net loss of 2 holders — while 3 trimmed existing stakes and 3 added.
The largest buyer was Spark Investment Management, adding an estimated $122K. The largest seller was Senvest Management, exiting entirely with an estimated $210K sold.
- 23 institutional investors held Marrone Bio Innovations, Inc. (MBII) as of Q4 2016, down from 25 in Q3 2016.
- Funds reported $19.5M of Marrone Bio Innovations, Inc. stock for Q4 2016, up 22% quarter-over-quarter.
- 3 funds opened new Marrone Bio Innovations, Inc. positions in Q4 2016 and 5 closed out, a net change of -2 holders.
- The largest Marrone Bio Innovations, Inc. buyer in Q4 2016 was Spark Investment Management, an estimated $122K added.
- The largest Marrone Bio Innovations, Inc. seller in Q4 2016 was Senvest Management, an estimated $210K sold.
Based on aggregated 13F filings for Q4 2016.